top of page
Mapa Asistencia Simposio 2020.png
Above the Clouds

VI International Heart Failure Summit 

Heart Failure and Pulmonary Hypertension Management in the Polypharmacy and Device Era 


Heart Failure Review 2021

Liotta Symposium

November 29 - December 04, 2021


New Heart Failure Definition & New Pathophysiologic Pathway

Polypharmacy 1, 2, 3, 4, 5 ,6 …. Therapies in Heart Failure

Cardiometabolic disease and Heart Failure (iSGLT2, GLP-1 agonist)


Focus in 

Amyloidosis. Newer approaches. Early diagnosis and treatment

Devices and remote monitoring for HFREF & HFPEF

Preserved EF HF. Different Phenotypes. Newer therapies. 


New Cardiogenic Shock Guidelines


Interventional Heart Failure

Percutaneous Mitral Repair (Focus on Mitraclip)Aortic Stenosis: Low Flow Low gradient Low EF


Arrhythmias Control in Heart Failure

Multimodality imaging in HF.


Hypertrophic Cardiomyopathy (HCOM/HCM)


Pulmonary Hypertension. Different therapeutics approaches. Upfront vs sequential strategy. NOACs


Percutaneous and Durables Ventricular Assist Devices


Total Artificial Heart

Simposios Imagen v1.2.png
Lic. Sofia Barbagelata

Academic Coordinator
Sofia Barbagelata, Certified nutritionist

bottom of page